Diffusion-Weighted MRI Versus 18F-FDG PET/CT: Performance as Predictors of Tumor Treatment Response and Patient Survival in Patients With Non–Small Cell Lung Cancer Receiving Chemoradiotherapy

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?

(2010) T. S. Aukema et al.   JOURNAL OF NUCLEAR MEDICINE

Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer

(2010) Dae Ho Lee et al.   Journal of Thoracic Oncology

Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study

(2009) T Okuma et al.   BRITISH JOURNAL OF RADIOLOGY

Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer☆

(2009) Naoki Kanauchi et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Detection of bone metastases in non-small cell lung cancer patients: Comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy

(2009) Daisuke Takenaka et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography

(2008) Takeshi Mori et al.   Journal of Thoracic Oncology

Non–Small Cell Lung Cancer: Whole-Body MR Examination for M-Stage Assessment—Utility for Whole-Body Diffusion-weighted Imaging Compared with Integrated FDG PET/CT

(2008) Yoshiharu Ohno et al.   RADIOLOGY

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer

(2007) Noriaki Sunaga et al.   LUNG CANCER